Non Hodgkin Lymphoma Incidence and Mortality by Year, Black Individuals, New York State, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 98 6.1 4.8-7.6 49 7.7 5.4-10.5 49 5.1 3.7-6.8 57 4.0 2.9-5.3 34 6.0 4.0-8.7 23 2.6 1.6-4.0
1977 118 7.1 5.7-8.6 57 8.5 6.2-11.5 61 6.1 4.6-8.0 61 3.8 2.8-5.1 28 4.2 2.5-6.6 33 3.5 2.3-5.1
1978 156 8.9 7.5-10.6 84 10.8 8.4-13.6 72 7.4 5.7-9.5 65 3.7 2.8-4.7 41 5.6 3.9-7.9 24 2.3 1.4-3.5
1979 115 6.8 5.5-8.2 64 8.5 6.3-11.2 51 5.4 3.9-7.2 79 5.2 4.0-6.7 42 6.0 4.1-8.4 37 4.5 3.1-6.4
1980 133 7.5 6.2-9.0 69 9.6 7.1-12.5 64 6.2 4.7-8.0 73 4.3 3.2-5.5 42 5.7 3.9-8.0 31 3.3 2.1-4.7
1981 131 7.5 6.1-9.0 66 7.7 5.7-10.2 65 7.0 5.3-9.0 78 4.4 3.4-5.5 34 4.8 3.2-7.0 44 4.1 2.9-5.6
1982 163 8.5 7.2-10.1 81 9.8 7.6-12.5 82 7.5 5.9-9.4 61 3.6 2.7-4.7 30 4.3 2.7-6.5 31 3.2 2.1-4.5
1983 173 8.7 7.4-10.1 85 9.8 7.6-12.4 88 7.8 6.2-9.7 91 4.8 3.8-5.9 49 5.8 4.1-7.9 42 4.0 2.8-5.4
1984 190 9.3 7.9-10.8 96 11.0 8.7-13.8 94 8.1 6.4-9.9 95 4.8 3.8-5.9 54 6.3 4.5-8.4 41 3.7 2.6-5.0
1985 233 10.9 9.4-12.4 125 13.6 11.0-16.6 108 8.9 7.2-10.8 108 5.3 4.3-6.5 55 6.0 4.3-8.2 53 4.7 3.5-6.2
1986 242 11.5 10.0-13.1 122 14.1 11.4-17.3 120 9.8 8.0-11.8 102 4.9 3.9-6.0 52 6.0 4.2-8.1 50 4.1 3.0-5.5
1987 252 11.2 9.8-12.8 150 16.4 13.5-19.6 102 7.7 6.3-9.4 95 4.4 3.5-5.4 50 5.6 4.0-7.6 45 3.5 2.6-4.8
1988 232 10.2 8.8-11.6 137 14.5 11.9-17.4 95 7.3 5.8-8.9 117 5.7 4.7-6.9 76 9.9 7.5-12.8 41 3.3 2.3-4.5
1989 272 11.2 9.9-12.7 155 14.4 12.0-17.1 117 8.7 7.2-10.5 115 5.1 4.2-6.2 67 7.2 5.3-9.4 48 3.7 2.7-5.0
1990 312 12.4 11.0-14.0 185 16.2 13.8-19.0 127 9.2 7.7-11.1 106 4.7 3.8-5.7 55 5.9 4.2-7.9 51 3.9 2.9-5.2
1991 312 12.7 11.3-14.3 180 16.4 13.8-19.3 132 9.8 8.1-11.6 109 4.8 3.9-5.9 62 6.1 4.5-8.0 47 3.8 2.7-5.0
1992 361 14.4 12.9-16.1 212 19.2 16.5-22.2 149 10.6 9.0-12.5 114 5.0 4.1-6.0 60 6.3 4.6-8.3 54 4.0 3.0-5.3
1993 367 13.5 12.1-15.0 227 19.0 16.5-21.8 140 9.2 7.7-10.9 117 4.9 4.0-5.9 55 5.1 3.7-6.7 62 4.5 3.4-5.8
1994 407 15.7 14.2-17.4 233 20.3 17.6-23.3 174 12.0 10.3-14.0 115 4.9 4.0-6.0 57 5.7 4.2-7.5 58 4.3 3.2-5.5
1995 384 14.6 13.1-16.2 239 21.3 18.4-24.5 145 9.8 8.2-11.6 118 4.9 4.0-5.9 65 5.8 4.4-7.5 53 3.9 2.9-5.1
1996 414 15.4 13.9-17.0 228 18.8 16.3-21.6 186 12.3 10.6-14.2 125 5.3 4.3-6.3 58 6.0 4.4-8.0 67 4.8 3.7-6.0
1997 432 16.1 14.6-17.8 248 21.9 19.0-25.0 184 12.0 10.3-13.9 116 4.9 4.0-5.9 60 6.3 4.7-8.3 56 3.9 2.9-5.1
1998 437 15.8 14.3-17.4 244 21.1 18.3-24.2 193 12.2 10.5-14.0 142 5.8 4.8-6.8 73 7.3 5.6-9.3 69 4.7 3.7-6.0
1999 463 16.4 14.9-18.0 251 21.1 18.4-24.0 212 13.0 11.3-14.9 146 5.5 4.6-6.5 79 7.5 5.8-9.5 67 4.3 3.3-5.5
2000 401 13.6 12.3-15.0 210 16.9 14.5-19.5 191 11.3 9.7-13.0 141 5.2 4.4-6.2 84 7.8 6.1-9.8 57 3.6 2.7-4.6
2001 435 15.0 13.6-16.5 235 19.0 16.5-21.7 200 12.0 10.4-13.8 153 5.7 4.8-6.7 78 7.0 5.4-8.9 75 4.7 3.7-5.9
2002 431 14.2 12.9-15.6 232 17.8 15.5-20.3 199 11.5 9.9-13.2 153 5.4 4.6-6.4 87 7.6 6.0-9.5 66 4.0 3.1-5.0
2003 464 15.4 14.0-16.9 214 17.0 14.7-19.6 250 14.3 12.6-16.2 136 4.7 3.9-5.5 71 6.1 4.7-7.8 65 3.8 2.9-4.8
2004 425 14.2 12.8-15.6 218 17.8 15.4-20.5 207 11.8 10.2-13.5 123 4.3 3.6-5.2 65 5.5 4.2-7.1 58 3.4 2.6-4.5
2005 483 15.6 14.3-17.1 243 18.6 16.2-21.2 240 13.5 11.9-15.4 123 4.4 3.6-5.2 63 5.7 4.3-7.4 60 3.5 2.7-4.5
2006 462 14.9 13.6-16.4 229 17.6 15.3-20.2 233 13.0 11.4-14.8 115 3.8 3.1-4.5 54 4.4 3.2-5.8 61 3.4 2.6-4.4
2007 484 15.3 13.9-16.7 272 20.2 17.8-22.9 212 11.7 10.2-13.4 131 4.4 3.6-5.2 64 5.5 4.2-7.1 67 3.8 2.9-4.8
2008 508 15.8 14.4-17.2 287 21.0 18.6-23.7 221 11.9 10.4-13.6 114 3.7 3.0-4.5 60 5.0 3.7-6.5 54 2.9 2.2-3.8
2009 517 16.2 14.8-17.7 254 18.9 16.5-21.5 263 14.4 12.7-16.2 120 3.8 3.1-4.6 63 5.0 3.8-6.5 57 3.1 2.3-4.0
2010 504 15.4 14.0-16.8 260 18.6 16.2-21.1 244 12.9 11.3-14.6 127 4.1 3.4-4.9 61 4.8 3.6-6.3 66 3.6 2.8-4.6
2011 575 17.1 15.7-18.6 316 23.1 20.5-26.0 259 13.2 11.6-14.9 134 4.3 3.6-5.1 76 6.0 4.6-7.6 58 3.1 2.3-4.0
2012 526 15.4 14.1-16.8 258 18.0 15.7-20.4 268 13.6 12.0-15.4 123 3.7 3.1-4.5 63 5.0 3.8-6.5 60 3.0 2.3-3.9
2013 539 15.4 14.1-16.8 270 18.4 16.2-20.8 269 13.3 11.8-15.0 123 3.7 3.1-4.4 64 4.8 3.7-6.2 59 2.9 2.2-3.8
2014 575 15.9 14.6-17.3 308 20.3 18.0-22.8 267 12.8 11.3-14.5 136 4.0 3.3-4.7 72 5.5 4.3-7.0 64 3.1 2.4-4.0
2015 577 15.9 14.6-17.3 275 18.2 16.0-20.5 302 14.4 12.8-16.1 127 3.7 3.1-4.4 62 4.7 3.6-6.1 65 3.1 2.4-3.9
2016 612 16.8 15.5-18.2 305 20.2 17.9-22.7 307 14.6 13.0-16.3 132 3.7 3.1-4.4 66 4.7 3.6-6.0 66 3.1 2.4-3.9
2017 592 16.0 14.7-17.3 287 18.5 16.4-20.9 305 14.4 12.8-16.1 136 3.7 3.1-4.4 77 5.2 4.1-6.5 59 2.7 2.1-3.5
2018 566 15.1 13.8-16.4 301 19.0 16.8-21.3 265 12.3 10.8-13.9 123 3.3 2.7-3.9 70 4.6 3.5-5.8 53 2.4 1.8-3.2
2019 599 15.7 14.4-17.0 317 19.7 17.5-22.0 282 12.9 11.4-14.6 150 4.0 3.4-4.7 84 5.6 4.4-7.0 66 3.0 2.3-3.8
2020 505 13.2 12.1-14.5 266 16.5 14.5-18.6 239 10.9 9.6-12.5 110 2.8 2.3-3.4 62 3.7 2.8-4.8 48 2.1 1.6-2.9

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.